Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
Sorà
Federica
F
Chiusolo
Patrizia
P
Piccirillo
Nicola
N
Pagano
Livio
L
Laurenti
Luca
L
Farina
Giuliana
G
Sica
Simona
S
Leone
Giuseppe
G
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D000077336:Caspofungin; D016503:Drug Delivery Systems; D025141:Drug Resistance, Fungal; D054714:Echinocandins; D006801:Humans; D055666:Lipopeptides; D008081:Liposomes; D008297:Male; D010455:Peptides; D010456:Peptides, Cyclic; D013154:Spleen / Q000382:microbiology*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008081:Liposomes; D010455:Peptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin